TPO and melanoma: In addition, concurrent suppression of these pathways induces expression of thyroid iodide-handling genes (sodium iodine transporter, thyroglobulin, and thyroid peroxidase) within melanoma cells, allowing for the uptake of radio iodide and potentially indicating radioiodine ablation therapy as an adjuvant to current melanoma treatment.6